[BREAKING] Hemerion obtains the FDA clearance for its next US clinical trial

Mount Sinai researchers advance our understanding of brain cancer

Hemerion technology introduced in the Friedman Brain Institute Falls Newsletter

Researchers from the Mount Sinai Health system introduce their ambitious research and development program to fight Glioblastoma in the recent Friedman Brain Institute Falls Newsletter, including the evaluation of the Hemerion technology. Encompassing the Icahn School of Medicine and eight hospital campuses in the New York metropolitan area, Mount Sinai is internationally acclaimed for its …

Read more